Alliances
Even clinical trial announcements don’t slow down for Halloween. It was a typically busy week. Here’s a look.
“This strategic collaboration with BeiGene will enable Amgen to serve significantly more patients by expanding our presence in the world’s most populous country,” said Robert A. Bradway, Amgen’s chairman and chief executive officer.
Under the terms of the deal, Roche will pay Dicerna $200 million upfront and up to another $1.47 billion for various development, regulatory and commercial milestones.
SeraNovo B.V. announced that it has signed a License Agreement with Carna Biosciences, Inc., a company engaged in drug development specializing in the development of kinase inhibitors.
Dow and Evonik have entered into an exclusive technology partnership. Together, they plan to bring a unique method for directly synthesizing propylene glycol (PG) from propylene and hydrogen peroxide to market maturity.
Disc Medicine is focused on hepcidin biology to restore red blood cell production in hematologic diseases.
For the third part of a six-part series examining the six most in-demand biotech careers, we take a detailed look at the rising career of an operations research analyst.
Ziopharm said the collaboration with the vaunted cancer research center will use non-viral gene transfer to stably express and clinically evaluate neoantigen-specific T-cell receptors in T cells.
ImmunoQure AG, a biotechnology company focused on the development of autoantibodies as therapeutics to treat human diseases and Memo Therapeutics AG, a biotechnology company focused on the discovery and development of therapeutic antibodies from cognate paired antibody libraries today announced the establishment of a collaborative partnership to create libraries from APS-1 memory B cells.
Amarantus Bioscience Holdings, Inc. announced it has entered into a binding term sheet to license its therapeutic assets to Emerald Organic Growth, Inc., a fully-integrated, CBD-based health sciences company launching branded products via its nationwide distribution channels.
PRESS RELEASES